Enteric targeting through enteric coating

Drug Targeting Technology: Physical Chemical Biological Methods

Volumn , Issue , 2016, Pages 1-29

  Brögmann, Bianca ^a   Beckert, Thomas E ^b  

^a MUNDIPHARMA GMBH   (Germany)

^b Rohm GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542641152     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. J. Krämer, H.-J. Pfefferle, H. Blume, Magensaftresistent überzogene Zubereitungen, Encyclopedia of Pharmaceutical Technology, Marcel Dekker, New York, Volume 14:355-384 (1996).
2. P. C. Schmidt, K. Teuber, Magensaftresistenz-gibt es die überhaupt?, Pharmazie in unserer Zeit 20:164-178 (1991).
3. K. Bauer, K. Fröming, C. Führer, Lehrbuch der pharmazeutischen Technologie, Verlag, 1999, p. 194.
4. J. Fordtran, T. Locklear, Ionic Constituents and Osmolality of Gastric and Smallintestinal Fluids After Eating, Harper and Row Publishers Inc., New York, New Series:11(7): (1966).
5. J. Spitael, R. Kinget, Factors affecting the dissolution rate of enteric coatings, Pharm Ind 39:502 (1977).
6. S. S. Davis, J. G. Hardy, J. M. Taylor, D. R. Whalley, C. G. Wilson, The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet), Int J Pharm 21:331-340 (1984).
7. J. N. Hung, D. F. Stubbs, The volume and energy content of meals as determinants of gastric emptying, J Physiol 215:209-225 (1975).
8. P. Mojaverian, M. L. Rocci, D. P. Conner, W. B. Abreuns, P. H. Vlasses, Effect of food on the absorption of enteric-coated aspirin, Correlation with gastric residence time, Clin Pharmacol Ther 41(1):11-17 (1987).
9. H. H. Blume, B. S. Schug, H. Potthast, Influence of food on the bioavailability of controlled/modified release products, Food-Drug Interactions (J. Kuhlmann, T. R. Weihrauch, eds.), W. Zuckschwerdt Verlag, München, Germany, 1995, pp. 25-33.
10. R. O. Williams III, M. Sriwongjanya, J. Liu, An in vitro method to investigate food effects on drug release from film-coated beads, Pharm Dev Technol 2:1-9 (1997).
11. G. M. Clarke, J. M. Newton, Gastrointestinal transit of pellets of differing size and density, Int J Pharm 100:81-92 (1993).
12. J. H. Meyer, J. Elashoff, V. Porter-Fink, J. Dressman, G. L. Amidon, Human postprandial gastric emptying of 1-3 millimeter spheres, Gastroenterology 94:1315-1325 (1988).
13. M. Kamba, Y. Seta, N. Suzuki, A. Kusai, K. Nishimura, Evaluation of destructive force in human stomach and small intestine, Proc Int Symp Control Rel Bioact Mater 23:579-580 (1996).
14. G. M. Clarke, J. M. Newton, M. B. Short, Comparative gastrointestinal transit of pellet systems of varying density, Int J Pharm 114:1-11 (1995).
15. G. M. Clarke, J. M. Newton, M. B. Short, Gastrointestinal transit of pellets of differing size and density, Int J Pharm 100:81-92 (1993).
16. J. Coupe, S. S. Davis, D. F. Evans, I. R. Wilding, Do pellet formulations empty from stomach with food?, Int J Pharm 92:167-175 (1993).
17. P. Gupta, J. Robinson, Effect of meal viscosity on gastric pH and residual volume in the fasted dog, Int J Pharm 109:91-98 (1994).
18. N. Reppas, J. Dressman, Viscosity modulates blood glucose response to nutrient solutions in dogs, Diabetes Research and Clinical Practice 17:81-88 (1992).
19. T. L. Russell, R. R. Berardi, J. L. Barnett, L. C. Dermentzoglou, K. M. Jarvenpaa, S. P. Schmaltz, J. B. Dressmann, Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women, Pharm Res 10:187 (1993).
20. K. Barnes, J. Ingram, A. J. Kenny, Proteins of the kidney microvillar membrane. Structural and immunochemical properties of rat endopeptidase-2 and its immunohistochemical location in tissues of rat and mouse, Biochem J 264:335-346 (1989).
21. P. Langguth, V. Bohner, J. Heizmann, H. P. Merkle, S. Wolffram, G. L. Amidon, S. Yamashita, The challenge of proteolytic enzymes in intestinal peptide delivery, J Controlled Release 46:39-57 (1997).
22. K. Lehmann, B. Brögmann, Tablet Coating, Encyclopedia of Pharmaceutical Technology, Volume 14:355-384 (1996).
23. H. Kokubo, S. Obara, K. Minemura, T. Tanaka, Development of cellulose derivatives as novel enteric coating agents soluble at pH 3.5-4.5 and higher, Chem Pharm Bull 45:1350-1353 (1997).
24. A. G. Eshra, Der Einfluß von sauer oder basisch reagierenden Modellsubstanzen auf die Stabilität von Filmumhüllungen beim Wechsel von organischen auf wäßrige Herstellungsmethoden, Dissertation, Freiburg 1982.
25. T. Waaler, S. A. Sande, B. W. Müller, G. Schüller-Lisether, The influence of thermal neutron irradiation on the in vitro characteristics of ASA oral dosage forms-Validation of neutron activation, Eur J Pharm Biopharm 43:159-164 (1997).
26. K. Steed, G. Hooper, P. Ventura, R. Musa, I. R. Wilding, The in vivo behaviour of a colonic delivery system: a pilot study in man, Int J Pharm 112:199-206 (1994).
27. T. Tabata, T. Makino, J. Kikuta, S. Hirai, N. Kitamori, Manufacturing method of stable enteric granules of a new antiulcer drug (lansoprazole), Drug Dev Ind Pharm 20(9):1661-1672 (1994).
28. J. McGinity, Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, Marcel Dekker, New York, 1996.
29. K. Lehmann, Acrylic latices from redispersible powders for peroral and transdermal drug formulations, Drug Dev Ind Pharm 12:265-287 (1986).
30. J. Plaizier-Vercammen, G. Suenens, Evaluation of Aquateric, a pseudolatex of cellulose acetate phthalate, for its enteric coating properties on tablets; STP Pharma Sci 5:307-312 (1991).
31. Shin-Etsu, Technical Bulletin, No. A-3, Synthapharm, Mühlheim-Ruhr, Germany, September 1996.
32. Y. Kané, J. Rambaud, H. Malliols, J. P. Laget, D. Gaudy, H. Delonca, Technological evaluation of three enteric coating polymers-II. With a soluble drug; Drug Dev Ind Pharm 20:1021-1034 (1994).
33. K. Lehmann, D. Dreher, Permeable acrylic resin coatings for the manufacture of depot preparations of drugs, Drugs Made in Germany 11:34 (1968).
34. P. Delporte, Il Farmaco 30:111 (1975).
35. K. Lehmann, Mixtures of aqueous polymethacrylate dispersions for drug coating, Drugs Made in Germany 31:101-102 (1988).
36. K. Bauer, K. Lehmann, H. Osterwald, G. Rothgang, Coated Pharmaceutical Dosage Forms, Medpharm Scientific Publishers, Stuttgart, 1998.
37. USP 24, Delayed Release (Enteric-Coated) Articles-General Drug Release Standard 724, U.S. Pharmacopoeial Convention Inc., Rockwell, MD, 1999.
38. M. L. Bender, L. J. Burbacher, Catalysis and Enzyme Action, McGraw Hill, New York, 1973, p. 52.
39. R. Wilding, S. S. Davis, F. Pozzi, P. Furlani, A. Gazzaniga, Enteric coated timed release for colonic targeting, Int J Pharmaceutics 111:99-102 (1994).
40. T. Levien, D. Baker, Reviews of naproxen enteric coated and varicella vaccine Hosp Pharm 30:1011-1024 (1995).
41. K. Lehmann, Formulation of controlled release tablets with acrylic resins Acta Pharm Fenn 93:55-74 (1984).
42. J. J. Orozco-Alcala, J. Baum, Regular and enteric coated aspirin: a revolution, Arthritis Rheum 22(9):1034-1037 (1979).
43. E. B. Bogentoft, P.-O. Lagerström, Comparison of two enteric-coated acetylsalicylic acid preparations by monitoring steady state levels of salicylic acid and its metabolites in plasma and urine, Biopharm Drug Dispos 5:251-260 (1984).
44. M. Marvola, J. Heinämaki, E. Westermarck, J. Hepponen, The fate of single-unit enteric-coated drug products in the stomach of the dog, Acta Pharm Pennica 95: 59-70 (1986).
45. V. Vilivalam, L. L. Illum, K. K. Iqbal, Starch capsules: an alternative system for oral drug delivery, Pharm Sci Technol Today 3(2):64-69 (2000).
46. B. Brögmann, K. Lehmann, Stability of enteric gelatin and starch capsules with aqueous dispersions of methacrylic acid copolymers; AAPS Annual Congress, San Diego, 1994.
47. I. Cherretté, J. Plaizier-Vercammen, Evaluation of a water dispersion of aquateric for its enteric coating properties of hard gelatine capsules manufactured with a fluidized bed technique, Pharm Acta Helv 67:227-230 (1992).
48. L. A. Felton, M. M. Haase, N. H. Shah, G. Zhang, M. H. Infeld, A. W. Malick, J. W. McGinity, Physical and enteric properties of soft gelatin capsules coated with Eudragit L30 D-55, Int J Pharm 113:17-24 (1995).
49. G. Digenis, The in vivo behaviour of multiparticulate versus single unit dose formulations, Capsugel Symposium, Seoul and Tokyo, 1990.
50. H. Bechgaard, K. Ladefoged, Gastrointestinal transit time of single-unit tablets, J Pharm Pharmacol 33:791-792 (1981).
51. H. Bechgaard, Critical factors influencing gastrointestinal absorption-What is the role of pellets? Acta Pharm Tech 28:149-157 (1982).
52. T. Beckert, K. Lehmann, P. C. Schmidt, Compression of enteric-coated pellets to disintegrating tablets, Int J Pharm 143:13-23 (1996).
53. T. Beckert, K. Lehmann, P. C. Schmidt, Compression of enteric-coated pellets to disintegrating tablets: Uniformity of dosage units, Powder Tech 96:248-254 (1998).
54. K. Walter, G. Weiß, A. Laicher, F. Stanislaus, Pharmacokinetics of ibuprofen following single administration of a suspension containing enteric-coated microcapsules, Drug Res 45:886-890 (1995).
55. J. G. Wagner, Disintegration of dosage forms in vitro and in vivo Part IV, Drug Intell Clin Pharm 3:324-330 (1969).
56. K. Lehmann, B. Brögmann, C. J. Kenyon, J. R. Wilding, The in vivo behaviour of enteric naproxen tablets coated with an aqueous dispersion of methacrylic acid copolymer, S.T.P. Pharma Sci 7(6):403-437 (1997).
57. W. A. Habib, A. Sakr, Effect of methacrylic acid copolymer USP/NF type C and the release of polypeptide drug nisin, AAPS, Annual Congress Boston, November 1997.
58. J. B. Dressman, G. L. Amidon, Radiotelemetric method for evaluating enteric coatings in vivo, J Pharm Sci 73(7):935-938 (1984).
59. P. Mojaverian, M. L. Rocci, D. P. Conner, W. B. Abreuns, P. H. Vlasses, Effect of food on the absorption of enteric-coated aspirin: Correlation with gastric residence time, Clin Pharmacol Ther 41(1):11-17 (1987).
60. D. Gardner, R. Casper, F. Leith, J. Wilding, Non-invasive methodology for assessing regional drug absorption from the gastrointestinal tract, Pharm Techn Europe 46-53, June (1997).
61. M. Marvola, M. Rajamniemi, E. Marttila, K. Vahervuo, A. Sothmann, Effect of dosage form and formulation on the adherence of drugs to the esophagus, J Pharm Sci 72:1034-1036 (1983).
62. J.-C. Chaumeil, Y. Piton, Enrobages gastro-résitants al'acetophthalate de cellulose II.-Relation entre l'épensseur du film et la résitance de l'enrobage in vivo, Annales Pharmaceutique Francaises 31(11):691-704 (1973).
63. M. E. M. van Golderen, M. Oeling, D. M. Barends, J. Meulenbelt, P. Salomons, A. G. Rauws, The bioavailability of diclofenac from enteric coated products in healthy volunteers with normal and artificially decreased gastric acidity, Biopharm Drug Disp 15:775-788 (1994).
64. M. S. Gordon, A. Fratis, R. Goldblum, D. Jung, E. Kenneth, K. E. Schwartz, Z. T. Chowhan, In vivo and in vitro evaluation of four different aqueous polymeric dispersions for producing an enteric coated tablet, Int J Pharmaceut 115:29-34 (1995).
65. S. A. Qureshi, G. Caillé, Y. Lacasse, I. J. McGilveray, Pharmacokinetics of two enteric coated ketoprofen products in humans with or without coadministration of omeprazole and comparison with dissolution findings, Pharm Res 11(11):1669-1672 (1994).
66. M. Mauro, G. C. Palmien, E. Palazzine, M. Barbanti, F. C. Rindina, M. R. Milani, Pharmacodynamic effects of single and repeated doses of oral sulodexide in healthy volunteers. A placebo-controlled study with an enteric-coated formulation, Curr Med Res Opin 13:87-95 (1993).
67. W. Stüber, E. Mutschler, D. Steinbach, The pharmaceutical and biological availability of commercial preparations of furosemide, Arzneim Forsch/Drug Res 32(I), 6, 693-697 (1982).
68. A. Litwin, M. Flanagan, G. Entis, G. Gottschlich, R. Esch, P. Gartside, J. G. Michael, Oral immunetherapy with short ragweed extract employing a novel encapsulated preparation-a double blind study, J Allergy Clin Immunol 1-34 (1996).
69. J. Leroux, R. Cozens, J. L. Roesel, B. Galli, F. Kubel, E. Doelker, R. Gurny, Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice, J Pharm Sci 84(12):1387-1391 (1995).
70. H. Staib, U. Fuhr, Drug absorption differences along the gastrointestinal tract in man: detection and relevance for the development of new drug formulations, Food-Drug Interactions (J. Kuhlmann, T. R. Weihrauch, eds.). W. Zuckschwerdt Verlag, München, Germany, 1995, pp. 34-56.
71. A. A. Deshpande, N. H. Shah, C. T. Rhodes, W. Malick, Development of a novel controlled-release system for gastric retention, Pharm Res 14:815-819 (1997).
72. B. C. Lippold, B. H. Lippold, Physibalisch-chemisches Verbalten von polymethacrylsauve derivation, Pharm Ind 35:854ff (1973).
73. P. H. List, G. Kaosio, Water vapor and oxygen permeability of various tablet coatings, Acta Pharm Techn 28(1) 1982.